The global Cold Remedies market size was valued at USD 9612.2 million in 2023 and is forecast to a readjusted size of USD 12480 million by 2030 with a CAGR of 3.8% during review period.
Cold is an infectious disease that affects the respiratory system. The common symptoms for cold include sneezing, sore throat, a stuffy nose, and coughing. Cold remedies are used to treat cold in immunosuppressed individuals.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report includes an overview of the development of the Cold Remedies industry chain, the market status of Hospital Pharmacies (Antihistamines, Expectorants), Retail Pharmacies (Antihistamines, Expectorants), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cold Remedies.
Regionally, the report analyzes the Cold Remedies markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cold Remedies market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cold Remedies market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cold Remedies industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Units), revenue generated, and market share of different by Type (e.g., Antihistamines, Expectorants).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cold Remedies market.
Regional Analysis: The report involves examining the Cold Remedies market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cold Remedies market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cold Remedies:
Company Analysis: Report covers individual Cold Remedies manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cold Remedies This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Cold Remedies. It assesses the current state, advancements, and potential future developments in Cold Remedies areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cold Remedies market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Cold Remedies market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
麻豆原创 segment by Type
Antihistamines
Expectorants
Bronchodilators
Decongestants
Antibiotics
Others
麻豆原创 segment by Application
Hospital Pharmacies
Retail Pharmacies
Others
Major players covered
Reckitt Benckiser
Johnson & Johnson
GlaxoSmithKline
Novartis
Bayer
AstraZeneca
Sun Pharmaceutical Industries
Pfizer
Prestige Brands
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cold Remedies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cold Remedies, with price, sales, revenue and global market share of Cold Remedies from 2019 to 2024.
Chapter 3, the Cold Remedies competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cold Remedies breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Cold Remedies market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cold Remedies.
Chapter 14 and 15, to describe Cold Remedies sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Cold Remedies
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Cold Remedies Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Antihistamines
1.3.3 Expectorants
1.3.4 Bronchodilators
1.3.5 Decongestants
1.3.6 Antibiotics
1.3.7 Others
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Cold Remedies Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Others
1.5 Global Cold Remedies 麻豆原创 Size & Forecast
1.5.1 Global Cold Remedies Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Cold Remedies Sales Quantity (2019-2030)
1.5.3 Global Cold Remedies Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Reckitt Benckiser
2.1.1 Reckitt Benckiser Details
2.1.2 Reckitt Benckiser Major Business
2.1.3 Reckitt Benckiser Cold Remedies Product and Services
2.1.4 Reckitt Benckiser Cold Remedies Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Reckitt Benckiser Recent Developments/Updates
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Cold Remedies Product and Services
2.2.4 Johnson & Johnson Cold Remedies Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Johnson & Johnson Recent Developments/Updates
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Cold Remedies Product and Services
2.3.4 GlaxoSmithKline Cold Remedies Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 GlaxoSmithKline Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Cold Remedies Product and Services
2.4.4 Novartis Cold Remedies Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Novartis Recent Developments/Updates
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Cold Remedies Product and Services
2.5.4 Bayer Cold Remedies Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Bayer Recent Developments/Updates
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Cold Remedies Product and Services
2.6.4 AstraZeneca Cold Remedies Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 AstraZeneca Recent Developments/Updates
2.7 Sun Pharmaceutical Industries
2.7.1 Sun Pharmaceutical Industries Details
2.7.2 Sun Pharmaceutical Industries Major Business
2.7.3 Sun Pharmaceutical Industries Cold Remedies Product and Services
2.7.4 Sun Pharmaceutical Industries Cold Remedies Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Sun Pharmaceutical Industries Recent Developments/Updates
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Cold Remedies Product and Services
2.8.4 Pfizer Cold Remedies Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Pfizer Recent Developments/Updates
2.9 Prestige Brands
2.9.1 Prestige Brands Details
2.9.2 Prestige Brands Major Business
2.9.3 Prestige Brands Cold Remedies Product and Services
2.9.4 Prestige Brands Cold Remedies Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Prestige Brands Recent Developments/Updates
3 Competitive Environment: Cold Remedies by Manufacturer
3.1 Global Cold Remedies Sales Quantity by Manufacturer (2019-2024)
3.2 Global Cold Remedies Revenue by Manufacturer (2019-2024)
3.3 Global Cold Remedies Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Cold Remedies by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Cold Remedies Manufacturer 麻豆原创 Share in 2023
3.4.2 Top 6 Cold Remedies Manufacturer 麻豆原创 Share in 2023
3.5 Cold Remedies 麻豆原创: Overall Company Footprint Analysis
3.5.1 Cold Remedies 麻豆原创: Region Footprint
3.5.2 Cold Remedies 麻豆原创: Company Product Type Footprint
3.5.3 Cold Remedies 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Cold Remedies 麻豆原创 Size by Region
4.1.1 Global Cold Remedies Sales Quantity by Region (2019-2030)
4.1.2 Global Cold Remedies Consumption Value by Region (2019-2030)
4.1.3 Global Cold Remedies Average Price by Region (2019-2030)
4.2 North America Cold Remedies Consumption Value (2019-2030)
4.3 Europe Cold Remedies Consumption Value (2019-2030)
4.4 Asia-Pacific Cold Remedies Consumption Value (2019-2030)
4.5 South America Cold Remedies Consumption Value (2019-2030)
4.6 Middle East and Africa Cold Remedies Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Cold Remedies Sales Quantity by Type (2019-2030)
5.2 Global Cold Remedies Consumption Value by Type (2019-2030)
5.3 Global Cold Remedies Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Cold Remedies Sales Quantity by Application (2019-2030)
6.2 Global Cold Remedies Consumption Value by Application (2019-2030)
6.3 Global Cold Remedies Average Price by Application (2019-2030)
7 North America
7.1 North America Cold Remedies Sales Quantity by Type (2019-2030)
7.2 North America Cold Remedies Sales Quantity by Application (2019-2030)
7.3 North America Cold Remedies 麻豆原创 Size by Country
7.3.1 North America Cold Remedies Sales Quantity by Country (2019-2030)
7.3.2 North America Cold Remedies Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Cold Remedies Sales Quantity by Type (2019-2030)
8.2 Europe Cold Remedies Sales Quantity by Application (2019-2030)
8.3 Europe Cold Remedies 麻豆原创 Size by Country
8.3.1 Europe Cold Remedies Sales Quantity by Country (2019-2030)
8.3.2 Europe Cold Remedies Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Cold Remedies Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Cold Remedies Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Cold Remedies 麻豆原创 Size by Region
9.3.1 Asia-Pacific Cold Remedies Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Cold Remedies Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Cold Remedies Sales Quantity by Type (2019-2030)
10.2 South America Cold Remedies Sales Quantity by Application (2019-2030)
10.3 South America Cold Remedies 麻豆原创 Size by Country
10.3.1 South America Cold Remedies Sales Quantity by Country (2019-2030)
10.3.2 South America Cold Remedies Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Cold Remedies Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Cold Remedies Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Cold Remedies 麻豆原创 Size by Country
11.3.1 Middle East & Africa Cold Remedies Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Cold Remedies Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Cold Remedies 麻豆原创 Drivers
12.2 Cold Remedies 麻豆原创 Restraints
12.3 Cold Remedies Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Cold Remedies and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cold Remedies
13.3 Cold Remedies Production Process
13.4 Cold Remedies Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cold Remedies Typical Distributors
14.3 Cold Remedies Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Reckitt Benckiser
Johnson & Johnson
GlaxoSmithKline
Novartis
Bayer
AstraZeneca
Sun Pharmaceutical Industries
Pfizer
Prestige Brands
听
听
*If Applicable.
